Nuveen Asset Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 95,665 shares of AMPH stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,665
Previous 207,972
54.0%
Holding current value
$2.99 Million
Previous $10.1 Million
64.8%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding AMPH
# of Institutions
274Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$185 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$84.7 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$57.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$49.8 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$42.9 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.53B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...